Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bone turnover biomarkers in COPD patients randomized to either a regular or shortened course of corticosteroids: a substudy of the randomized controlled CORTICO-COP trial.
Sivapalan P, Jørgensen NR, Mathioudakis AG, Eklöf J, Lapperre T, Ulrik CS, Andreassen HF, Armbruster K, Sivapalan P, Janner J, Godtfredsen N, Weinreich UM, Nielsen TL, Seersholm N, Wilcke T, Schuetz P, Klausen TW, Marså K, Vestbo J, Jensen JU. Sivapalan P, et al. Among authors: lapperre t. Respir Res. 2020 Oct 12;21(1):263. doi: 10.1186/s12931-020-01531-9. Respir Res. 2020. PMID: 33046053 Free PMC article. Clinical Trial.
Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids.
Kunz LI, Ten Hacken NH, Lapperre TS, Timens W, Kerstjens HA, van Schadewijk A, Vonk JM, Sont JK, Snoeck-Stroband JB, Postma DS, Sterk PJ, Hiemstra PS; GLUCOLD Study Group. Kunz LI, et al. Among authors: lapperre ts. Eur Respir J. 2017 Jan 3;49(1):1600839. doi: 10.1183/13993003.00839-2016. Print 2017 Jan. Eur Respir J. 2017. PMID: 28049170 Free article. Clinical Trial.
Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids.
Kunz LIZ, Ten Hacken NH, Lapperre TS, Timens W, Kerstjens HAM, van Schadewijk A, Vonk JM, Sont JK, Snoeck-Stroband JB, Postma DS, Sterk PJ, Hiemstra PS; GLUCOLD Study Group. Kunz LIZ, et al. Eur Respir J. 2017 Jun 15;49(6):1700848. doi: 10.1183/13993003.00848-2017. Print 2017 Jun. Eur Respir J. 2017. PMID: 28619964 Free article. No abstract available.
Evaluation of criteria for clinical control in a prospective, international, multicenter study of patients with COPD.
Miravitlles M, Sliwinski P, Rhee CK, Costello RW, Carter V, Tan J, Lapperre TS, Alcazar B, Gouder C, Esquinas C, García-Rivero JL, Kemppinen A, Tee A, Roman-Rodríguez M, Soler-Cataluña JJ, Price DB. Miravitlles M, et al. Respir Med. 2018 Mar;136:8-14. doi: 10.1016/j.rmed.2018.01.019. Epub 2018 Jan 31. Respir Med. 2018. PMID: 29501251 Free article.
Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial.
Sivapalan P, Lapperre TS, Janner J, Laub RR, Moberg M, Bech CS, Eklöf J, Holm FS, Armbruster K, Sivapalan P, Mosbech C, Ali AKM, Seersholm N, Wilcke JT, Brøndum E, Sonne TP, Rønholt F, Andreassen HF, Ulrik CS, Vestbo J, Jensen JS. Sivapalan P, et al. Among authors: lapperre ts. Lancet Respir Med. 2019 Aug;7(8):699-709. doi: 10.1016/S2213-2600(19)30176-6. Epub 2019 May 20. Lancet Respir Med. 2019. PMID: 31122894 Clinical Trial.
Pseudomonas aeruginosa and risk of death and exacerbations in patients with chronic obstructive pulmonary disease: an observational cohort study of 22 053 patients.
Eklöf J, Sørensen R, Ingebrigtsen TS, Sivapalan P, Achir I, Boel JB, Bangsborg J, Ostergaard C, Dessau RB, Jensen US, Browatzki A, Lapperre TS, Janner J, Weinreich UM, Armbruster K, Wilcke T, Seersholm N, Jensen JUS. Eklöf J, et al. Among authors: lapperre ts. Clin Microbiol Infect. 2020 Feb;26(2):227-234. doi: 10.1016/j.cmi.2019.06.011. Epub 2019 Jun 22. Clin Microbiol Infect. 2020. PMID: 31238116 Free article.
Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Sivapalan P, Ulrik CS, Bojesen RD, Lapperre TS, Eklöf JV, Håkansson KEJ, Browatzki A, Tidemansen C, Wilcke JT, Janner J, Gottlieb V, Meteran H, Porsbjerg C, Madsen BL, Moberg M, Pedersen L, Benfield TL, Lundgren JD, Knop FK, Biering-Sørensen T, Ghanizada M, Sonne TP, Bødtger UCS, Jensen SG, Rasmussen DB, Brøndum E, Tupper OD, Sørensen SW, Alstrup G, Laursen CB, Møller UW, Sverrild A, Jensen JS. Sivapalan P, et al. Among authors: lapperre ts. Trials. 2020 Jun 10;21(1):513. doi: 10.1186/s13063-020-04409-9. Trials. 2020. PMID: 32522282 Free PMC article.
TOB-STOP-COP (TOBacco STOP in COPd trial): study protocol-a randomized open-label, superiority, multicenter, two-arm intervention study of the effect of "high-intensity" vs. "low-intensity" smoking cessation intervention in active smokers with chronic obstructive pulmonary disease.
Saeed MI, Sivapalan P, Eklöf J, Ulrik CS, Pisinger C, Lapperre T, Tønnesen P, Hoyer N, Janner J, Karlsson ML, Bech CS, Marså K, Godtfredsen N, Brøndum E, Munk B, Raaschou M, Browatzski A, Lütken P, Jensen JS. Saeed MI, et al. Among authors: lapperre t. Trials. 2020 Aug 21;21(1):730. doi: 10.1186/s13063-020-04653-z. Trials. 2020. PMID: 32825845 Free PMC article.
69 results